NEO Exchange Announces Breakthrough Listing in Food Sector With IPO of Plantable Health
Retrieved on:
Wednesday, January 12, 2022
Retail, Health, Fitness & Nutrition, Clinical Trials, General Health, Food, Beverage, ETF, Doctor of Philosophy, Technology, Memorial Sloan Kettering Cancer Center, Inflammation, IPO, Growth, NEO Exchange, CEO, Health, Awareness, Company, Food, E-commerce, Neuroscience, Goldman Sachs, NEO, Johns Hopkins, Dietary supplement, Security (finance), Quantum chemistry, the NEO Exchange, Plantable Health Inc., THE NEO EXCHANGE, PLANTABLE HEALTH INC.
The NEO Exchange is proud to announce the public listing of Plantable Health Inc. (Plantable or the Company), a unique and clinically supported dietary intervention program focused on health and wellness.
Key Points:
- The NEO Exchange is proud to announce the public listing of Plantable Health Inc. (Plantable or the Company), a unique and clinically supported dietary intervention program focused on health and wellness.
- Our debut on the NEO Exchange is a significant milestone for our company as we look to leverage the capital markets to fuel our growth with the support of a Tier 1 exchange, commented Nadja Pinnavaia, CEO of Plantable.
- It is also our first public listing at the intersection of the food and healthcare sectors, commented Jos Schmitt, President and CEO of NEO.
- Plantable is a clinically supported lifestyle change program that combines behavioral psychology, neuroscience, and nutritional science to transform health and wellness.